
The RECOVERY trial, which released its results Tuesday, showed that dexamethasone lowered the death rate in badly sick patients by about third, according to Reuters.
“This is a result that shows that if patients who have COVID-19 and are on ventilators or are on oxygen are given dexamethasone, it will save lives, and it will do so at a remarkably low cost,” said Martin Landray, a co-leader on the trial.
The steroid is commonly used to reduce inflammation in patients battling other illnesses….more

